The Kangze Pharmacy brand is affiliated to Kangze Pharmaceutical Chain Co., Ltd. The company follows the advanced business philosophy of modern enterprises, implements standardized and refined management according to the corporate governance structure, takes customer satisfaction as the company's work goal, and solemnly promises to the majority of customers: Give me a requirement, and you are very satisfied! Chain companies strictly follow the requirements of GSP, have complete software and hardware facilities, and operate efficiently and orderly.
With the scale advantages and comprehensive strength of the parent company's comprehensive platform, Guangdong Kangze Pharmaceutical Chain Co., Ltd. has established a good corporate image of the Kangze brand with high efficiency and speed. Over the years, it has established good cooperative relationships with major well-known manufacturers at home and abroad, has a wide range of customer resources and unique supply channels, and has regional exclusive agents with many advantageous varieties, with strong resource advantages. It has formed a multi-level product series such as imported, joint ventures and domestic products, and now operates more than 8,000 pharmaceutical specifications to meet the needs of different customers. The company's main suppliers include: Bayer Pharmaceutical, Sino-US SK, Eisai, AstraZeneca, Xi'an Janssen, Hangzhou Sanofi, Wyeth, Avant, Schweiya, Hangzhou Merck, Squibb, Glaxo, Abbott, Boehringer Ingelheim, Beijing Novartis, Hunan Kangyuan, Yangtze River Pharmaceutical, Guangzhou Jingxiutang, Baiyun Pharmaceutical, Beijing Tongrentang, Beijing Shuanghe, Shijiazhuang Yiling, Zhangzhou Pinzihuang, Shandong Buchang, Zhejiang Jimin, Yunnan Baiyao, etc. The chain company and Shantou Kangze Pharmaceutical Co., Ltd. (both wholly owned subsidiary of the parent company and a pharmaceutical wholesale enterprise) have implemented integrated wholesale and retail operations, building a good development pattern of complementary advantages and resource sharing in wholesale and retail. It has now established a relatively strong sales network in Guangzhou, Shenzhen and Shantou. The distribution service covers the entire eastern Guangdong region and radiates to more than ten provinces and cities. It currently has more than 300 wholesale commercial customers, 2,000 terminal retail commercial customers, and more than 500 medical institutions. It has built an enterprise organizational structure with a wide coverage and complete business functions. The company has a professional distribution and transportation fleet, an administrative center with office automation, an information business center, and an intelligent logistics center. The company currently has a total office area of ​​more than 1,000 square meters and a total storage area of ​​more than 5,000 square meters. The increasing level of scale and specialization has provided strong guarantees for the rapid development of enterprise operations. More sufficient strength to ensure the quality and safety of drugs 100%. It can also improve operational efficiency, minimize operating costs, and provide customers with substantial value-added services. In order to promote sustainable and rapid development, at the end of 2012, the company established the Ministry of E-commerce, opened an e-commerce platform, obtained the first B2C qualification certificate in East Guangdong, and launched Kangze Online Pharmaceutical Mall, realizing the extension of traditional retail business to the e-commerce field. In 2013, we obtained the online transaction service qualification certificate for wholesale business, becoming the only pharmaceutical distribution company in East Guangdong that holds B2C and B2B certificates, providing a new development space for wholesale and retail businesses. Our strategic goal for the new year is to consolidate traditional businesses while accelerating the development of e-commerce businesses, keeping pace with the times to build a new development strategy, creating an upgraded version of the business model, and pushing enterprises to reach a new level of development.